Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
5 NC counties are under alert, including Johnston County.
Program
Friday at 6 on WRAL: How much does your county spend on education? WRAL Investigates which counties are prioritizing your children.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Paxmedica Inc
(NQ:
PXMD
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Paxmedica Inc
< Previous
1
2
3
4
Next >
PaxMedica Inc. (NASDAQ: PXMD) Shares Corporate Update and Commitment to Advancing Therapies for Neurological Disorders, Prepares for Key Engagements with the FDA
May 29, 2024
Via
Investor Brand Network
Study Discovers Elevated Risk of Toxicity Among Autistic Kids
May 24, 2024
Via
Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis
May 24, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Dedicated to Ensuring Access to Life-Saving Treatments
May 22, 2024
Via
Investor Brand Network
Researcher Wants to Untangle Environmental, Genetic Complexities of Autism
May 08, 2024
Via
Investor Brand Network
Rising Cases of Autism in UK Raise Concerns
March 08, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Appeals NASDAQ Delisting Decision, Prepares for June FDA Meeting
May 15, 2024
Via
Investor Brand Network
Exposures
Product Safety
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
May 15, 2024
From
PaxMedica, Inc.
Via
GlobeNewswire
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Continues Advancement of PAX-101 Regulatory Strategy
May 07, 2024
Via
Investor Brand Network
Exposures
Product Safety
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
May 07, 2024
From
PaxMedica, Inc.
Via
GlobeNewswire
PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA
May 01, 2024
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Featured in Latest Bell2Bell Podcast Release
April 26, 2024
Via
Investor Brand Network
“Urgent Action: PaxMedica Inc. (NASDAQ: PXMD) Addresses Medical Crisis in Malawi”
April 24, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDA
April 24, 2024
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Responds to Emergency Request for IV Suramin, Commits to Provide Immediate Access to PAX-101
April 23, 2024
Via
Investor Brand Network
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
April 23, 2024
From
PaxMedica, Inc.
Via
GlobeNewswire
Misinformation on TikTok Causing Many to Misdiagnose Themselves as Autistic
April 19, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) in Process of Responding to Emergency Request for IV Suramin from African Health Ministry
April 17, 2024
Via
Investor Brand Network
Exposures
Product Safety
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
April 16, 2024
From
PaxMedica, Inc.
Via
GlobeNewswire
InvestorNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Announces ‘Milestone Achievement’ on Journey to Developing PAX-101
April 12, 2024
Via
Investor Brand Network
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
April 11, 2024
From
PaxMedica, Inc.
Via
GlobeNewswire
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Developing Robust Product Lineup to Address ASD, Associated Neurodevelopmental Conditions
April 05, 2024
Via
Investor Brand Network
Prenatal Exposure to Caffeine and High-Fat Diets Heighten Autism Risk in Rodent Models
April 01, 2024
Via
Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Developing Pipeline to Address Unmet Needs in Autism Spectrum Disorder via Suramin Sodium
March 21, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) on Promising Path to Meet Medical Needs of ASD Patients
March 20, 2024
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Shares Vision, Innovations in ASD Treatments in Updated Company Presentation
March 13, 2024
Via
Investor Brand Network
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
March 13, 2024
From
PaxMedica, Inc.
Via
GlobeNewswire
PaxMedica Inc. (NASDAQ: PXMD) Pursues Autism Treatment as Diagnostic App Shows Promise to Effective ASD Diagnosis
March 08, 2024
Via
Investor Brand Network
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Committed to Developing Groundbreaking Therapies, Transformative Solutions
March 01, 2024
Via
Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Developing Pipeline of Products to Address Prevalence and Unmet Medical Needs of Autism Spectrum Disorder
February 20, 2024
Via
Investor Brand Network
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.